On behalf of the database, we also observed a growth inhibitory effect of the GPD2 inhibitor, KM04416, on several cancer cell lines including MDA-MB-231 (breast cancer) and AsPC-1 (pancreatic cancer) as well as Huh-7, HepG2, and SK-HEP-1 cells (liver cancer), except for PLC/PRF/5 cells (human hepatoma cell line) (Figure 6F). Here, GPD2 is linked to breast carcinoma.